{
    "id": 30000,
    "fullName": "AFAP1L2 - RET",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "AFAP1L2-RET results from the fusion of AFAP1L2 and RET, leading to increased Erk phosphorylation and cell proliferation, and is transforming in culture (PMID: 28351223). AFAP1L2-RET has been identified in thyroid cancer (PMID: 28351223).",
            "references": [
                {
                    "id": 12631,
                    "pubMedId": 28351223,
                    "title": "Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28351223"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 84632,
        "geneSymbol": "AFAP1L2",
        "terms": [
            "AFAP1L2",
            "CTB-1144G6.4",
            "KIAA1914",
            "XB130"
        ]
    },
    "variant": "AFAP1L2 - RET",
    "createDate": "05/03/2019",
    "updateDate": "06/05/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 5979,
                "geneSymbol": "RET",
                "terms": [
                    "RET",
                    "CDHF12",
                    "CDHR16",
                    "HSCR1",
                    "MEN2A",
                    "MEN2B",
                    "MTC1",
                    "PTC",
                    "RET-ELE1"
                ]
            }
        }
    ],
    "evidence": [
        
    ],
    "molecularProfiles": [
        {
            "id": 32114,
            "profileName": "AFAP1L2 - RET",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}